Pure Global

Qizhe prostate-specific antigen in vitro reagent set - Taiwan Registration 42ef4acee5503f3a8defc147a0ee71e6

Access comprehensive regulatory information for Qizhe prostate-specific antigen in vitro reagent set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 42ef4acee5503f3a8defc147a0ee71e6 and manufactured by Longteng Biotechnology Co., Ltd. The authorized representative in Taiwan is Qizhe Biotechnology Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
42ef4acee5503f3a8defc147a0ee71e6
Registration Details
Taiwan FDA Registration: 42ef4acee5503f3a8defc147a0ee71e6
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qizhe prostate-specific antigen in vitro reagent set
TW: ๅ•Ÿๅ“ฒๅ‰ๅˆ—่…บ็‰น็•ฐๆ€งๆŠ—ๅŽŸ้ซ”ๅค–่ฉฆๅŠ‘็ต„
Risk Class 2
Cancelled

Registration Details

42ef4acee5503f3a8defc147a0ee71e6

Company Information

Taiwan, Province of China

Product Details

Qualitative detection of prostate-specific antigen (PSA) in human serum and blood.

C Immunology and microbiology

C.6010 ่…ซ็˜ค็›ธ้—œๆŠ—ๅŽŸๅ…็–ซ่ฉฆ้ฉ—็ณป็ตฑ

Domestic;; Contract manufacturing

Dates and Status

Dec 11, 2013

Dec 07, 2016

Apr 25, 2018

Cancellation Information

Logged out

่‡ช่กŒ้ตๅ…ฅ